JPRN-UMIN000023873
Completed
未知
A study of evaluation to the predictive biomarker of Nivolumab in peripheral blood and pleural effusion. - A biomarker study of of Nivolumab in blood and pleural effusion.
Respiratory Medicine, Allergy and Rheu matic Diseases Osaka University Graduate School of Medicine0 sites10 target enrollmentAugust 31, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- previously treated patients with advanced non-small-cell lung cancer
- Sponsor
- Respiratory Medicine, Allergy and Rheu matic Diseases Osaka University Graduate School of Medicine
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)With interstitial pneumonia or pulmonary fibrosis on a chest X\-ray 2\)Clinically significant drug allergy 3\)Presencee of other active malignancy 4\)With pericardial effusion, pleural effusion and ascites in need of treatment of drainage 5\)Positive serum HBs antigen 6\)With severe infection, cardiac diseases, diabates, hypertention, other severe complication 7\)Patients received palliative radiotherapy for brain metastases and bone metastases, except for the primary lesion within 2weeks. 8\)Pregnancy or lactating patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Analysis of predictive biomarker and analysis of correlations between toxicities and SNPs that can be related to pharmacokinetics, in ramucirumab plus paclitaxel therapy for elderly patients with unresectable or recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000021743Tohoku Clinical Oncology Research and Education Society (T-CORE)30
Completed
Not Applicable
Analysis of predictive biomarker and analysis of correlations between toxicities and SNPs that can be related to pharmacokinetics, in trifluridine/tipiracil hydrochloride therapy for previously fluoropyrimidine-treated elderly patients with unresectable or recurrent colorectal cancerColorectal cancerJPRN-UMIN000021742Tohoku Clinical Oncology Research and Education Society (T-CORE)20
Recruiting
Not Applicable
Prospective validation of the prognostic biomarker CD8+ TEMRA cells for disturbed fracture healing.S82.1S82.2S82.3S82.7S82.11S82.18S82.31S72S72.1S72.2S72.3S72.4S72.7S72.8Fracture of upper end of tibiaFracture of shaft of tibiaFracture of lower end of tibiaMultiple fractures of lower legFracture of femurPertrochanteric fractureSubtrochanteric fractureFracture of shaft of femurFracture of lower end of femurMultiple fractures of femurFractures of other parts of femurDRKS00010872Charité Universitätsmedizin Berlin / Berlin-Brandenburger Centrum für Regenerative Therapien / Julius Wolff Institut800
Recruiting
Not Applicable
A biomarker assessment study to investigate the influence of high-frequency chest wall oscillations on the clearance of cerebrospinal fluid biomarkersNL-OMON51372Centre for Human Drug Research34
Not yet recruiting
Not Applicable
A prospective observational study of biomarkers for Second-line FOLFIRI plus Aflibercept treatment in patients with metastatic colorectal cancer comparing to FOLFIRI plus beVacizumab: an Exploratory biomarker study.colorectal cancerJPRN-UMIN000038508Kyoto University Hospital70